“…Little is known about second-generation DAAs skin AEs because clinical trials do not differentiate between types of skin “rashes” and the causes for drug discontinuation. 1 Isolated cases of leucocytoclasic vasculitis, 8 pityriasis rubra pilaris-like drug eruption, 9 Steven-Johnson Syndrome, 10 hand–foot syndrome, 11 erythema multiforme, 12 and photoinduced drug eruption 13,14 have been reported with sofosbuvir, alone or in combination with other DAAs.…”